
Medicine in Microecology, Год журнала: 2025, Номер unknown, С. 100133 - 100133
Опубликована: Май 1, 2025
Язык: Английский
Medicine in Microecology, Год журнала: 2025, Номер unknown, С. 100133 - 100133
Опубликована: Май 1, 2025
Язык: Английский
Movement Disorders Clinical Practice, Год журнала: 2025, Номер unknown
Опубликована: Март 13, 2025
Abstract Background The gut‐brain axis, i.e. the bidirectional communication system between gut and brain, has become of central importance in Parkinson disease (PD) research over past 20 years. Aims We aimed to describe milestones axis PD development theories proposing involvement gastrointestinal tract pathogenesis. Methods searched PubMed using terms ‘gut‐brain axis’ AND ‘Parkinson disease’, selected relevant articles provide foundation for reconstructing an historical overview PD. Results Mounting evidence from preclinical, clinical post‐mortem studies suggests that a subgroup patients present with range prodromal symptoms (e.g., autonomic dysfunction, rapid eye movement sleep behaviour disorder) which reflect initial accumulation later spread pathological α‐synuclein rostrally (“body‐first” PD). Through neural connections along may producing clinically manifest disease. Recently, two mechanisms involving have attracted increasing attention their role pathogenesis progression, namely perturbation composition microorganisms living (the microbiome), dysfunction enteroendocrine cells. Conclusion Treatments targeting especially microbiome cells pathway, could potentially slow progression or even prevent onset. Among these, pre/probiotics, faecal microbiota transplantation, glucagon‐like peptide‐1 receptor agonists, entered advanced stages trials humans shown potential symptomatic disease‐modifying effects.
Язык: Английский
Процитировано
1Translational Medicine of Aging, Год журнала: 2025, Номер 9, С. 41 - 48
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Journal of Neurology, Год журнала: 2025, Номер 272(6)
Опубликована: Май 21, 2025
Abstract Parkinson’s disease is the second most common neurodegenerative disorder and fastest growing neurological condition worldwide, yet its etiology progression remain poorly understood. This characterized pathologically by prion-like spread of misfolded neuronal alpha-synuclein proteins in specific brain regions leading to Lewy body formation, neurodegeneration, progressive impairment. It unclear what triggers where α-synuclein protein aggregation begins, although proposed induction sites include olfactory bulb dorsal motor nucleus vagus nerve. Within last 20 years, there has been increasing evidence that could be triggered early microbiome changes accumulation gastrointestinal system. Gut microbiota dysbiosis alters motility, permeability, inflammation enable from gut-to-brain via enteric nervous Individuals with isolated rapid eye movement sleep behavior have a high likelihood developing might represent prodromal ‘gut-first’ subtype condition. The gut-first model offers novel gut-based therapeutic avenues, such as anti-, pre-, pro-biotic preparations fecal transplants. Crucially, interventions offer an avenue treat at stages aim mitigating evolution clinically recognizable
Язык: Английский
Процитировано
0Medicine in Microecology, Год журнала: 2025, Номер unknown, С. 100133 - 100133
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0